Delivery Order SPE2DR25D2009-SPE2DR26FJ3S2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $17,351.77. The contract is a firm fixed price delivery order with an ultimate completion date of December 5, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's performance location for this order is Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $41,055.70 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and requires completion by December 5, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This non-set-aside, competitively awarded contract carries a ceiling value of $1,801.51 and is scheduled for completion by December 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $38,433.94 on December 5, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of December 8, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary operations center. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $15,257.22 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill this order from its corporate office location. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $13,675.68. This non-set-aside, competitively awarded contract carries a firm fixed price structure and is scheduled for completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,708.90 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on December 5, 2025, with completion anticipated by December 8, 2025. This firm fixed-price contract, which is not set-aside, leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $4,970.25 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery transaction under AmerisourceBergen's existing pharmaceutical supply framework. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency has awarded a delivery order valued at $26,313.07 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 11, 2025. The contract does not include a set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes valued at $12,767.10, with completion scheduled for September 24, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ3S2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $4,574.98. This competitively awarded, non-set-aside contract employs firm fixed pricing and is scheduled for ultimate completion by December 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and operates as a critical pharmaceutical distributor supporting federal medical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract reflects AmerisourceBergen's demonstrated capability to fulfill federal medical supply needs through open competition and its established role as a primary pharmaceutical vendor within the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 12/1/25 |